posttranscript
gene
silenc
ptg
make
possibl
new
approach
studi
variou
step
viral
cycl
plusstrand
rna
virus
appear
attract
target
small
interf
rna
sirna
genom
function
mrna
replic
templat
ptg
creat
altern
classic
revers
genet
virus
either
negativestrand
doublestrand
rna
genom
larg
genom
ptg
allow
modif
express
given
cellular
gene
mean
elucid
role
viral
cycl
virushost
cell
interact
investig
cellular
pathway
involv
viral
pathogenesi
also
allow
creation
new
anim
model
human
diseas
addit
ptg
alreadi
appear
promis
new
therapeut
tool
fight
viral
multipl
dissemin
host
prevent
inflamm
virusinduc
pathogenesi
includ
virusinduc
tumorigenesi
small
noncod
nc
rna
import
role
regul
wide
rang
cellular
pathway
associ
development
program
protect
genom
mobil
genet
element
particular
small
interf
rna
sirna
molecul
mediat
posttranscript
gene
silenc
ptg
natur
biolog
phenomenon
discov
plant
caenorhabd
elegan
plant
natur
conserv
mechan
antivir
immun
ptg
mediat
sirna
produc
type
iii
endoribonucleas
dicer
process
doublestrand
ds
rna
precursor
elbashir
et
al
demonstr
synthet
nt
long
rna
duplex
transfect
cultur
cell
silenc
gene
sequencespecif
manner
synthet
sirna
two
nucleotid
overhang
mimic
produc
ribonucleas
dicer
digest
larg
dsrna
duplex
rna
shorter
base
pair
bp
gener
activ
nonspecif
suppress
dsrnadepend
protein
kinas
incorpor
rnainduc
silenc
complex
risc
one
sirna
strand
act
guid
select
homolog
target
mrna
cleav
degrad
rnase
fig
effici
sirna
gener
greater
short
antisens
rna
one
characterist
sirna
activ
must
perfectli
basepair
target
correspond
rna
howev
g
u
wobbl
base
pair
alter
target
specif
probabl
thermodynam
stabil
watsoncrick
base
pair
small
duplex
rna
name
micro
rna
mirna
also
depend
dicer
process
requir
perfect
complementar
mrna
target
block
gene
express
translat
inhibit
mechan
therefor
differ
ptg
highli
sequencespecif
recent
shown
transfect
small
duplex
rna
display
one
mismatch
target
sequenc
sometim
behav
like
mirna
inhibit
translat
mrna
remain
intact
prefer
sirna
target
sequenc
chosen
outsid
rna
region
predict
highli
structur
guidelin
choic
sirna
sequenc
publish
includ
g
c
bp
end
sens
strand
sirna
bp
atrich
sequenc
end
antisens
strand
sirna
gc
stretch
longer
bp
enzymat
prepar
sirna
synthes
sever
way
improv
effici
lower
cost
one
approach
larg
duplex
rna
cleav
vitro
clone
dicer
occur
cell
advantag
produc
larg
panel
sirna
cover
long
segment
mrna
therebi
enhanc
effici
case
virus
avoid
emerg
escap
mutant
anoth
method
involv
use
polymeras
transcrib
sirna
short
dna
templat
encod
sirna
downstream
promot
one
limit
chemic
enzymat
synthes
sirna
transient
effect
transfect
anim
cell
chemic
protect
sirna
viral
vector
use
circumv
problem
sirna
technolog
power
lead
revolut
molecular
virolog
make
possibl
new
approach
studi
variou
step
viral
cycl
plusstrand
rna
virus
fig
also
kind
virus
ptg
creat
altern
classic
revers
genet
virus
either
negativestrand
dsrna
genom
larg
genom
ptg
allow
modif
express
given
cellular
gene
mean
elucid
role
viral
cycl
virushost
cell
interact
investig
cellular
pathway
involv
viral
pathogenesi
also
allow
creation
new
anim
model
human
diseas
addit
ptg
alreadi
appear
promis
new
therapeut
tool
fight
viral
multipl
dissemin
host
prevent
inflamm
virusinduc
pathogenesi
includ
virusinduc
tumorigenesi
see
literatur
ptg
alreadi
substanti
review
far
exhaust
exampl
chosen
among
rna
dna
viru
famili
illustr
possibl
alreadi
offer
new
technolog
retrovirus
consid
subject
separ
review
journal
sirna
neg
charg
readili
cross
cell
membran
introduc
cell
electropor
altern
deliveri
vehicl
two
class
use
synthet
carrier
cation
lipid
peptid
cation
polym
review
viral
vector
nonvir
carrier
present
fewer
safeti
concern
viral
vector
gener
less
effect
deliveri
effect
chemic
enzymat
synthes
sirna
gener
transient
typic
last
week
prolong
effect
rna
polymeras
iiidriven
small
rna
express
vector
construct
induc
longlast
rna
silenc
mammalian
cell
sirna
transcrib
rna
polymeras
iii
promot
stretch
five
residu
act
transcript
termin
signal
posit
neg
strand
sirna
obtain
either
tandemtyp
hairpintyp
transcript
construct
insert
sever
type
vector
includ
lentiviru
adenoviru
adenoassoci
viru
aav
vector
longterm
express
sirna
small
hairpin
rna
shrna
last
sever
week
therebi
obtain
note
lentivirus
suitabl
vector
use
nondivid
cell
particular
certain
primari
cell
cultur
episom
vector
also
design
one
transfect
cell
synthet
sirna
phosphoryl
helicas
may
associ
risc
lead
sirna
unwind
antisens
strand
sirna
guid
complex
toward
cognat
mrna
target
rna
cleav
endoribonucleas
risc
homologydepend
manner
result
mrna
degrad
see
refer
text
contain
ori
p
origin
replic
code
sequenc
protein
requir
episom
mainten
two
tandem
promot
drive
synthesi
sirna
strand
method
commonli
use
vivo
includ
electropor
sirna
neural
tube
chick
embryo
hydrodynam
inject
tail
vein
mice
sirna
also
deliv
intranas
subcutan
viral
vector
routin
use
vivo
region
viral
genom
assay
target
ptg
plusstrand
rna
virus
appear
attract
target
sirna
genom
function
mrna
replic
templat
pioneer
studi
gitlin
et
al
target
capsid
protein
region
rna
polymeras
region
polioviru
pv
genom
shown
viral
yield
onestep
growth
cycl
lower
cell
transfect
specif
antivir
sirna
infect
antivir
sirna
interf
viral
multipl
earli
infect
depend
viral
replic
induc
specif
posttranscript
cleavag
degrad
viral
rna
cell
protect
slightli
extend
anticapsid
antipolymeras
sirna
use
togeth
neither
interferon
ifn
either
dsrnaactiv
effector
pkr
rnase
l
requir
suppress
pv
replic
sirna
interestingli
escap
pv
mutant
rapidli
emerg
cell
treat
singl
sirna
infect
high
multipl
infect
moi
rare
emerg
lower
moi
suggest
alreadi
present
initi
viral
popul
dnabas
human
hepat
viru
hav
replicon
use
hepatoma
cell
line
investig
whether
hav
replic
inhibit
sirna
target
region
replicon
encod
nonstructur
protein
specif
inhibit
complet
suppress
hav
replic
demonstr
pv
combin
sirna
effect
singl
sirna
suppress
viral
replic
unexpectedli
two
havspecif
sirna
induc
increas
replicon
express
thu
ptg
ineffect
case
probabl
secondari
structur
target
rna
may
influenc
effici
ptg
similar
phenomenon
also
observ
case
human
hepat
c
viru
hcv
replicon
sirna
specif
first
nucleotid
hcv
nc
region
exhibit
stemloop
structur
given
medic
import
hcv
infect
sever
laboratori
investig
possibl
inhibit
replic
hcv
cell
line
hepat
origin
sinc
effici
cell
cultur
system
growth
hcv
avail
studi
perform
hcv
replicon
harbor
report
gene
andor
select
marker
hcvspecif
sirna
effect
inhibit
hcv
replic
least
ifnand
cell
cycleindepend
manner
protocol
involv
two
three
success
transfect
endonucleaseprepar
sirna
highli
effect
mice
sirna
target
viral
polymeras
region
reduc
express
hcv
chimera
inhibit
dna
templat
encod
shrna
use
hepatomaderiv
cell
line
alreadi
harbor
autonom
replic
subgenom
hcv
rna
luciferas
activ
reduc
doserespons
manner
transfect
cell
specif
sirna
target
nc
region
hcv
prolong
sirna
effect
obtain
bicistron
plasmid
express
complementari
sirna
wilson
et
al
use
selfcontain
episom
express
vector
extend
durat
sirna
activ
week
introduct
sirna
target
anoth
nonstructur
protein
result
inhibit
activ
promot
well
inhibit
core
protein
express
sirna
target
core
region
also
result
dosedepend
specif
hcv
rna
silenc
sirna
reduc
level
strand
rna
could
clear
replic
hcv
rna
cell
hcv
gene
also
appear
good
target
ptg
dengu
viru
denv
anoth
plusstrand
rna
viru
great
medic
import
caus
dengu
hemorrhag
fever
respons
dengu
shock
syndrom
aav
vector
encod
sirna
specif
nc
sequenc
common
dengu
serotyp
reduc
dengu
infect
dendrit
cell
decreas
dengueinduc
apoptosi
cell
novel
coronaviru
cov
respons
sever
acut
respiratori
syndrom
sar
spread
worldwid
earli
viru
sarscov
like
member
coronavirida
famili
envelop
larg
genom
posit
polar
sirna
target
sarscov
rna
polymeras
block
cytopath
effect
viru
vero
cell
block
viral
rna
protein
synthesi
reduc
viru
product
molecular
genet
difficult
virus
either
negativestrand
rna
genom
segment
genom
larg
genom
virus
sirna
technolog
offer
potenti
valuabl
altern
strategi
modul
viral
gene
express
negativestrand
rna
virus
includ
import
human
pathogen
among
pediatr
diseas
caus
human
respiratori
syncyti
viru
hrsv
claim
million
live
annual
nonseg
genom
antigenom
rna
hrsv
escap
sirna
probabl
tightli
wrap
nucleocapsid
protein
n
make
inaccess
unlik
fulllength
genom
antigenom
rna
mrna
bind
n
protein
two
type
hrsvspecif
sirna
design
first
specif
p
protein
involv
format
complex
respons
sustain
rna
elong
transcript
second
specif
fusion
protein
f
nanomolar
concentr
sirna
specif
viral
p
f
mrna
abolish
express
correspond
mrna
protein
produc
expect
mutant
phenotyp
target
p
mrna
substanti
diminish
viral
protein
product
reduc
viral
progeni
yield
fold
inhibit
cell
fusion
contrast
target
f
mrna
inhibit
cytopath
effect
complet
prevent
syncytia
format
therefor
hrsvspecif
sirna
allow
function
genom
studi
attenu
infect
revers
genet
analysi
studi
hostviru
signal
pathway
influenza
virus
anoth
group
major
human
pathogen
virus
caus
particularli
sever
respiratori
infect
elderli
immunocompromis
individu
one
advantag
sirna
treatment
requir
function
immun
system
genom
influenza
viru
compos
eight
rna
segment
neg
polar
ge
et
al
design
sirna
target
region
viral
genom
conserv
among
differ
subtyp
strain
viru
human
anim
speci
viral
gene
target
except
hemagglutinin
neuraminidas
gene
extens
divers
gene
sirna
target
nucleocapsid
protein
np
two
protein
transcriptas
complex
pa
effect
even
cell
infect
viru
hour
prior
sirna
introduct
addit
sirna
inhibit
influenza
viru
product
vitro
also
inhibit
viru
product
chicken
embryo
interestingli
author
demonstr
target
sirna
either
mrna
complementari
strand
crna
viral
strand
rna
howev
target
np
pa
gene
result
overal
inhibit
viral
rna
transcript
influenza
viru
matrix
proteinencod
rna
also
success
target
rotavirus
lead
etiolog
agent
sever
diarrhea
young
children
worldwid
consist
three
concentr
layer
protein
enclos
genom
segment
dsrna
dimer
form
spike
surfac
triplelay
particl
tlp
involv
viru
attach
cell
surfac
sirna
correspond
gene
effici
inhibit
synthesi
synthesi
viral
protein
affect
viral
particl
tlp
lack
result
report
dector
et
al
indic
requir
bud
doublelay
particl
dlp
endoplasm
reticulum
envelop
intermedi
particl
lose
lipid
envelop
requir
assembl
third
protein
layer
assembl
loos
manner
condit
form
spikeless
tlp
result
particl
poorli
infecti
find
confirm
essenti
role
infect
rotaviru
interestingli
viral
transcript
involv
viru
genom
replic
seem
suscept
sirna
may
either
protect
within
electrondens
inclus
viroplasm
rnabind
protein
cytoplasm
synthesi
silenc
even
correspond
sirna
ad
h
postinfect
silenc
gene
prevent
format
tlp
caus
dlp
accumul
silenc
viral
polymeras
nonstructur
protein
block
secondari
transcript
viru
concomit
inhibit
synthesi
viral
protein
review
anoth
potenti
target
sinc
viral
enterotoxin
contribut
diarrhea
review
absenc
revers
genet
system
ptg
use
function
genom
studi
rotavirus
herpesvirus
larg
dna
virus
typic
infect
host
latent
acut
phase
reactiv
lytic
viru
cycl
may
occur
follow
induct
variou
agent
two
human
gammaherpesvirus
kaposi
sarcoma
associ
herpesviru
kshv
epsteinbarr
viru
ebv
associ
sever
type
malign
jia
sun
target
rta
gene
murin
gammaherpesviru
herpesviru
encod
immediateearli
viral
protein
respons
switch
latent
lytic
phase
also
target
gene
conserv
among
gammaherpesvirus
make
good
target
antirta
sirna
cotransfect
viru
dna
permiss
cell
significantli
block
rta
express
also
block
express
viral
protein
cell
cotransfect
either
antirtaor
grew
better
control
produc
viru
progeni
day
posttransfect
herp
simplex
viru
type
alphaherpesviru
infect
epitheli
neuron
cell
glycoprotein
e
ge
essenti
celltocel
spread
human
keratinocyt
transfect
gespecif
sirna
infect
bhuyan
et
al
observ
small
plaqu
correspond
phenotyp
gedelet
mutant
human
polyomaviru
jc
respons
demyelin
diseas
progress
multifoc
leukoencephalopathi
success
block
ptg
human
astrocyt
cell
hepat
b
viru
hbv
caus
acut
chronic
infect
human
liver
lead
develop
liver
cirrhosi
hepatocellular
carcinoma
stabl
hbvproduc
hepatoma
cell
line
sirna
target
polyadenyl
precor
hbv
surfac
antigen
hbsag
significantli
decreas
abund
correspond
hbv
rna
particular
small
hbsag
select
target
sirna
major
transcript
synthes
genom
region
hbv
replic
overlap
includ
pregenom
rna
serv
templat
revers
transcript
synthesi
viral
dna
mrna
mice
inject
either
hbsagspecif
sirna
plasmid
encod
shrna
togeth
plasmid
encod
entir
hbv
genom
result
declin
hbv
serum
marker
level
concomitantli
antivir
sirna
treatment
greatli
reduc
number
hbsagand
coreposit
hepatocyt
sirna
treatment
caus
inflammatori
infiltr
liver
tissu
first
cellular
molecul
involv
viral
multipl
receptor
respons
viru
bind
entri
cell
receptor
particularli
interest
target
silenc
absenc
receptor
block
subsequ
step
viral
cycl
gaggar
et
al
use
sirna
demonstr
role
ubiquit
express
complement
regulatori
protein
cellular
attach
receptor
group
b
adenovirus
similarli
role
ubiquit
glucos
transport
compon
receptor
human
cell
leukemia
viru
htlv
demonstr
downmodul
endogen
express
sirna
specif
nc
region
mrna
knockdown
ptg
reduc
human
coronaviru
infect
viru
bind
raft
enter
cell
caveola
sirna
encod
adenoviru
vector
use
confirm
role
put
cellular
cofactor
hcv
sinc
viral
replic
hepatoma
cell
substanti
block
silenc
either
la
protein
potenti
involv
hcv
intern
initi
translat
polypyrimidin
tract
bind
protein
protein
interact
region
subunit
gamma
eukaryot
initi
factor
cofactor
hcv
capindepend
translat
similarli
target
human
rna
helicas
specif
sirna
caus
reduct
transcript
negativestrand
hcv
rna
denv
serotyp
transmit
human
mosquito
aed
aegypti
aed
albopictu
sindbi
viru
express
vector
use
studi
role
mosquito
gene
determin
mosquito
compet
viru
dissemin
sanchezvarga
et
al
engin
sindbi
viru
genom
contain
code
region
earli
trypsin
trypearl
protein
regul
proteolyt
cascad
midgut
bloodf
mosquito
recombin
sindbi
viru
transcrib
region
trypearl
gene
trypearlsirna
produc
mosquito
midgut
lead
degrad
trypearl
mrna
importantli
affect
dissemin
tissu
head
ptg
thu
use
identifi
cellular
gene
involv
viral
dissemin
mosquito
baculoviru
autographa
californica
nucleopolyhedrosi
viru
caus
sever
econom
loss
silk
industri
mani
year
interf
gene
essenti
baculoviru
virul
major
nucleocapsid
gene
earli
transcript
activ
inhibit
viral
infect
prevent
death
insect
footandmouth
diseas
viru
fmdv
picornaviru
etiolog
agent
devast
diseas
clovenhoof
anim
footandmouth
diseas
w
chen
et
al
engin
plasmid
encod
capsid
protein
sirna
inject
subcutaneouli
neck
suckl
mice
treatment
render
mice
less
suscept
fmdv
promot
surviv
interestingli
preadministr
plasmid
encod
transcript
contribut
protect
anim
result
agreement
observ
effect
sirna
may
longlast
target
mrna
continu
avail
murin
model
also
use
show
sirna
specif
highli
conserv
region
nucleoprotein
np
acid
polymeras
pa
influenza
viru
inhibit
viral
replic
vivo
intraven
intranas
rout
inocul
use
success
virusspecif
sirna
reduc
viru
titer
lung
protect
mice
lethal
challeng
highli
pathogen
avian
influenza
virus
subtyp
ifn
could
respons
inhibit
viru
replic
virus
resist
antivir
effect
ifn
addit
ge
et
al
shown
sirna
given
influenza
viru
infect
reduc
viru
replic
lung
mice
demonstr
therapeut
effect
sirna
human
cervic
cancer
harbor
human
papillomaviru
hpv
genom
cooper
effect
hpv
gene
drive
cell
transform
interact
key
tumor
suppressor
retinoblastoma
protein
prb
respect
silenc
gene
cervic
carcinoma
cell
posit
result
select
mrna
degrad
nuclear
accumul
stabil
accompani
induct
express
cell
cycl
control
protein
protein
target
reduc
cell
growth
although
substanti
arrest
observ
sirna
specif
induc
signific
cell
death
contrast
silenc
gene
induc
select
loss
hyperphosphoryl
cellular
prb
caus
cell
round
undergo
apoptosi
therefor
case
hpvposit
human
carcinoma
cell
treatment
sirna
lead
select
kill
cancer
cell
furthermor
squamou
carcinoma
model
new
zealand
white
rabbit
infect
cottontail
rabbit
papillomaviru
role
specif
cellular
gene
cell
invas
shown
ptg
rou
sarcoma
viru
rsv
caus
abnorm
prolifer
tissu
disorgan
chick
embryo
plasmid
encod
deriv
rsv
modifi
use
retrovir
vector
either
rsv
gagspecif
sirna
nonspecif
sirna
control
introduc
neural
tube
chick
embryo
electropor
day
fertil
effect
assess
day
later
embryo
electropor
rsv
plu
control
sirna
dead
time
abnorm
misplac
prolif
cell
wherea
receiv
rsv
plu
gagspecif
sirna
indistinguish
uninfect
embryo
therefor
rsvinduc
abnorm
cell
prolifer
tissu
disorgan
revers
ptg
although
rna
interfer
extrem
power
tool
new
technolog
sever
limit
rna
virus
show
high
degre
sequenc
divers
differ
genotyp
rapid
evolut
quasispeci
mutat
recombin
gener
reassort
genom
case
segment
genom
major
problem
develop
sirnabas
gene
therapi
addit
larg
section
highli
structur
untransl
region
viral
rna
genom
resist
ptg
sirna
even
enhanc
express
instead
silenc
effect
other
offtarget
effect
therefor
silenc
wrong
gene
sirna
may
also
crossreact
target
limit
similar
escap
mutant
emerg
treatment
cell
singl
virusspecif
sirna
particular
cell
infect
high
moi
design
multipl
sirna
target
differ
region
viral
genom
particular
wellconserv
region
reduc
probabl
gener
escap
mutant
addit
studi
shown
transfect
sirna
result
ifnmedi
activ
jakstat
pathway
gener
upregul
ifnstimul
gene
effect
mediat
dsrnadepend
protein
kinas
pkr
depend
concentr
sirna
bridg
et
al
also
note
shrna
produc
lentivir
vector
induc
ifn
respons
wherea
homolog
chemic
synthes
sirna
howev
synthet
sirna
induc
ifn
respons
sirna
caus
tolllik
receptor
induc
type
ifn
sequenceindepend
mrna
degrad
cours
acut
infect
keratinocyt
therefor
recommend
use
lowest
effect
dose
sirna
sirnaencod
vector
ptg
suppressor
protein
identifi
plant
anim
virus
although
molecular
mechan
silenc
inhibit
still
poorli
understood
flock
hous
viru
fhv
belong
nodavirida
famili
encod
protein
exhibit
potent
silencingsuppress
activ
transgen
plant
essenti
fhv
accumul
drosophila
cell
li
et
al
demonstr
fhv
trigger
strong
viru
rna
silenc
viru
equip
effect
silenc
suppressor
suggest
dsrnabind
protein
reoviru
outer
shell
protein
sigma
could
suppress
ptgsmediat
antivir
defens
vaccinia
viru
human
influenza
viru
encod
essenti
protein
suppress
rna
silenc
basedantivir
respons
drosophila
respect
suppressor
dsrnabind
protein
inhibit
ifnregul
innat
antivir
respons
result
suggest
ptg
play
role
nucleic
acidbas
antivir
immun
mammalian
cell
knowledg
molecular
mechan
ptg
come
studi
plant
c
elegan
drosophila
mammal
mechan
tissuespecif
characterist
ptg
still
need
investig
greater
detail
role
ptg
natur
antivir
respons
mammalian
cell
yet
confirm
transmiss
interfer
one
cell
anoth
remain
interest
question
investig
identif
viral
protein
ptg
suppressor
mammalian
cell
start
variou
effect
virus
ptg
cell
need
studi
nevertheless
ptg
alreadi
extrem
use
new
approach
viral
function
genom
alreadi
wide
use
character
role
cellular
protein
cycl
mani
virus
possibl
partial
silenc
allow
role
protein
requir
cell
viabil
studi
prevent
therapeut
effect
sirna
may
use
reinforc
cellular
pathway
involv
ptg
anim
diseas
prevent
virusspecif
sirna
may
use
human
therapeut
properti
sirna
probabl
develop
prevent
applic
today
remain
mani
problem
concern
deliv
appropri
amount
desir
sirna
appropri
tissu
right
time
sirna
test
absenc
toxic
stabil
probabl
chemic
modif
order
obtain
longlast
effect
despit
current
limit
sirna
technolog
target
either
viral
cellular
gene
promis
develop
treatment
diseas
neither
vaccin
effici
therapi
current
avail
